Literature DB >> 19591065

Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.

Jie Shi1, Su-xia Li, Xiao-li Zhang, Xi Wang, Bernard Le Foll, Xiang-Yang Zhang, Thomas R Kosten, Lin Lu.   

Abstract

RATIONALE: Heroin use and withdrawal cause abnormality in the endocrine system. However, the time course of neuroendocrine alterations in heroin addicts during pharmacologically unassisted withdrawal is still unclear.
OBJECTIVES: To investigate alterations in cortisol, adrenocorticotrophic hormone (ACTH), beta-endorphin (beta-EP), leptin, and neuropeptide Y (NPY) during the first month of abstinence in heroin addicts.
METHODS: Twelve heroin addicts and eight matched healthy control subjects were recruited for this study. The neuroendocrine alterations and self-reported heroin craving, anxiety, and depression in heroin addicts were assessed at different time points (days 3, 10, and 30) of first month of abstinence from heroin use.
RESULTS: Self-reported heroin craving, anxiety, and depression in heroin addicts decreased gradually during the first month of abstinence. The cortisol levels increased from abstinence day 3 to 30, while ACTH and beta-EP levels decreased over this period in heroin addicts. The leptin and NPY levels were significantly decreased on days 3 and 10 but had normalized on day 30 of abstinence. A positive correlation between cortisol level and heroin craving, anxiety, and depression was observed, while a negative correlation was observed between beta-EP level and craving and anxiety and between leptin and depression and NPY and anxiety.
CONCLUSIONS: Abnormal alterations in the neuroendocrine system, including levels of cortisol, ACTH and beta-EP persist throughout the first month of abstinence. These results suggest that neuroendocrine system dysfunctions in heroin abusers is independent of the acute and protracted withdrawal syndromes, and may thus contribute to relapse to heroin use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591065     DOI: 10.1080/00952990902933878

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  16 in total

1.  Longitudinal changes of dopamine transporters in heroin users during abstinence.

Authors:  Shasha Xu; Ying Liu; Yu Li; Yangping Deng; Yiyun Huang; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Zhirui Guo; Mei Han; Xingdang Liu; Daxu Fu
Journal:  Psychopharmacology (Berl)       Date:  2015-06-23       Impact factor: 4.530

Review 2.  Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.

Authors:  Nicole M Enman; Yong Zhang; Ellen M Unterwald
Journal:  Pharmacol Biochem Behav       Date:  2013-12-11       Impact factor: 3.533

3.  The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis.

Authors:  Marc O Martel; Robert N Jamison; Ajay D Wasan; Robert R Edwards
Journal:  Pain Med       Date:  2014-03-10       Impact factor: 3.750

Review 4.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

5.  Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes.

Authors:  Ke Xu; Kwangik Adam Hong; Zhifeng Zhou; Richard L Hauger; David Goldman; Rajita Sinha
Journal:  Psychoneuroendocrinology       Date:  2011-09-13       Impact factor: 4.905

6.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

7.  A leptin-mediated central mechanism in analgesia-enhanced opioid reward in rats.

Authors:  Grewo Lim; Hyangin Kim; Michael F McCabe; Chiu-Wen Chou; Shuxing Wang; Lucy L Chen; John J A Marota; Anne Blood; Hans C Breiter; Jianren Mao
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

8.  Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs.

Authors:  David M Lydon-Staley; H Harrington Cleveland; Andrew S Huhn; Michael J Cleveland; Jonathan Harris; Dean Stankoski; Erin Deneke; Roger E Meyer; Scott C Bunce
Journal:  Addict Behav       Date:  2016-08-15       Impact factor: 3.913

9.  Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.

Authors:  Andrew S Huhn; Patrick H Finan
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.157

10.  Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats.

Authors:  Bombi Lee; Bongjun Sur; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.